Rinaman explained that when GLP-1R agonist drugs are given systemically, they are not recruiting the central GLP-1 endogenous neurons but are accessing a subset of the receptors
Following treatment discontinuation (after 2 years, or earlier due to non-response or adverse events), treatment effects were assumed to decline according to a catch-up rate until BMI returned to baseline
Early menopause, perimenopause, pre-menopause: here's what to expect GLP-1 and fertility The relationship between GLP-1 and fertility depends on individual circumstances, along with several other factors
Because obesity and insulin resistance impair ovulation, improving metabolic health may indirectly enhance fertility
This potentially offers superior outcomes in weight reduction and glycemic control
Studies show a dramatic initial weight loss that slows after 60 weeks as the appetite-suppressive effects appear to diminish